Evidence map›Paper›PMID 26066011›Full record

ArticleJournal of health communication2015

Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.

Robert J Volk, Gianna T Kinsman, Yen-Chi L Le, Paul Swank, Jennifer Blumenthal-Barby, Stephanie L McFall, Theresa L Byrd, Patricia Dolan Mullen, Scott B Cantor

Open access · greenAbstract read
In one paragraph

Article in Journal of health communication, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Robert J Volka Department of General Internal Medicine , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
Gianna T Kinsman
Yen-Chi L Le
Paul Swank
Jennifer Blumenthal-Barby
Stephanie L McFall
Theresa L Byrd
Patricia Dolan Mullen
Scott B Cantor
The University of Texas Health Science Center at Houston · USThe University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · USTexas Tech University · USUniversity of Essex · GB

Funding

BEHAVIORAL SCIENCE EDUCATION--CANCER PREVENTION/CONTROLR25CA057712 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MULLEN, PATRICIA DOLAN · 1992 to 2017
$8.6M
HEALTH PROMOTION AND DISEASE PREVENTION RESEARCH CENTERS - CENTER CATEGORY 1U48DP001949 · DP · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI TORTOLERO, SUSAN · 2009 to 2013
$7.9M
NCCDPHP CDC HHS 1U48DP001949-01NCCDPHP CDC HHS U48 DP001949NCI NIH HHS R25 CA057712NCI NIH HHS R25 CA57712
6 · The paper itself

Abstract

Active surveillance is increasingly recognized as a reasonable option for men with low-risk, localized prostate cancer, yet few men who might benefit from conservative management receive it. The authors examined the acceptability of normative messages about active surveillance as a management option for patients with low-risk prostate cancer. Men with a diagnosis of localized prostate cancer who were recruited through prostate cancer support organizations completed a web-based survey (N = 331). They rated messages about active surveillance for believability, accuracy, and importance for men to hear when making treatment decisions. The message "You don't have to panic … you have time to think about your options" was perceived as believable, accurate, and important by more than 80% of the survivors. In contrast, messages about trust in the active surveillance protocol and "knowing in plenty of time" if treatment is needed were rated as accurate by only about 36% of respondents. For active surveillance to be viewed as a reasonable alternative, men will need reassurance that following an active surveillance protocol is likely to allow time for curative treatment if the cancer progresses.

Indexed as

Attitude to HealthWatchful WaitingAgedAged, 80 and overDecision MakingDisease ProgressionHealth CommunicationHumansMaleMiddle AgedProstatic Neoplasms

Identifiers

PMID26066011
PMCPMC4784693
OpenAlexW1829311386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.